Evidence check: VDR in the context of weight loss

**Evidence Check: VDR (Vitamin D Receptor) in the Context of Weight Loss** The evidence for a direct, clinically meaningful role of the VDR gene in weight loss is weak to moderate. Observational studies and GWAS have reported associations between common VDR polymorphisms (e.g., FokI, BsmI, TaqI, ApaI) and BMI, body fat percentage, or dietary weight loss success. However, effect sizes are small, and findings are inconsistent – many studies find no significant link. Moreover, any effect is heavily confounded by environmental factors (vitamin D status, sun exposure, diet) and other genetic variants. **Practical Relevance:** A genetic test for VDR variants alone is insufficient to guide personalized weight loss strategies. The evidence does not support clear supplement or diet recommendations based on VDR genotype. Vitamin D deficiency should be addressed regardless, as it impacts overall health. Direct-to-consumer tests often overstate the predictive power of single SNPs. **Safety Note:** No direct risks from VDR testing, but false reassurance or unnecessary high-dose vitamin D supplementation can be harmful. For weight loss, focus on calorie balance, physical activity, and behavioral change.